BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27237743)

  • 1. Cell division cycle-associated protein 1 as a new melanoma-associated antigen.
    Tokuzumi A; Fukushima S; Miyashita A; Nakahara S; Kubo Y; Yamashita J; Harada M; Nakamura K; Kajihara I; Jinnin M; Ihn H
    J Dermatol; 2016 Dec; 43(12):1399-1405. PubMed ID: 27237743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinesin family member 20A is a novel melanoma-associated antigen.
    Yamashita J; Fukushima S; Jinnin M; Honda N; Makino K; Sakai K; Masuguchi S; Inoue Y; Ihn H
    Acta Derm Venereol; 2012 Nov; 92(6):593-7. PubMed ID: 22854760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.
    Tang Y; Cheng Y; Martinka M; Ong CJ; Li G
    Carcinogenesis; 2014 Jan; 35(1):86-95. PubMed ID: 24130172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
    Guo H; Cheng Y; Martinka M; McElwee K
    Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.
    Harao M; Hirata S; Irie A; Senju S; Nakatsura T; Komori H; Ikuta Y; Yokomine K; Imai K; Inoue M; Harada K; Mori T; Tsunoda T; Nakatsuru S; Daigo Y; Nomori H; Nakamura Y; Baba H; Nishimura Y
    Int J Cancer; 2008 Dec; 123(11):2616-25. PubMed ID: 18770861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER3 is a determinant for poor prognosis in melanoma.
    Reschke M; Mihic-Probst D; van der Horst EH; Knyazev P; Wild PJ; Hutterer M; Meyer S; Dummer R; Moch H; Ullrich A
    Clin Cancer Res; 2008 Aug; 14(16):5188-97. PubMed ID: 18698037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
    Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
    Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis.
    Kaneko N; Miura K; Gu Z; Karasawa H; Ohnuma S; Sasaki H; Tsukamoto N; Yokoyama S; Yamamura A; Nagase H; Shibata C; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1235-40. PubMed ID: 19878654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Tip60 in human melanoma cell migration, metastasis, and patient survival.
    Chen G; Cheng Y; Tang Y; Martinka M; Li G
    J Invest Dermatol; 2012 Nov; 132(11):2632-41. PubMed ID: 22673729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell division cycle associated 1 as a novel prognostic biomarker and therapeutic target for oral cancer.
    Thang PM; Takano A; Yoshitake Y; Shinohara M; Murakami Y; Daigo Y
    Int J Oncol; 2016 Oct; 49(4):1385-93. PubMed ID: 27499128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of patients with de novo versus nevus-associated melanoma.
    Lin WM; Luo S; Muzikansky A; Lobo AZ; Tanabe KK; Sober AJ; Cosimi AB; Tsao H; Duncan LM
    J Am Acad Dermatol; 2015 Jan; 72(1):54-8. PubMed ID: 25440436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer/testis genes expression in human melanoma cell lines.
    Mikhaylova IN; Kovalevsky DA; Morozova LF; Golubeva VA; Cheremushkin EA; Lukashina MI; Voronina ES; Burova OS; Utyashev IA; Kiselev SL; Demidov LV; Beabealashvilli RSh; Baryshnikov AY
    Melanoma Res; 2008 Oct; 18(5):303-13. PubMed ID: 18781128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression.
    Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C
    J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
    Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
    J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma.
    Flørenes VA; Emilsen E; Dong HP; Førsund M; Holm R; Slipicevic A
    Cancer Med; 2015 Jun; 4(6):903-13. PubMed ID: 25663244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.
    Yan S; Coffing BN; Li Z; Xie H; Brennick JB; Beg HA; Froehlich HM; Wells WA
    Anticancer Res; 2016 Jun; 36(6):2871-80. PubMed ID: 27272799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
    Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
    Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.